David Shprecher
Advanced in Tardive Dyskinesia

Dr. David Shprecher

Neurology
Banner Health
Banner Sun Health Research Institute
10515 West Santa Fe Drive, 
Sun City, AZ 
Clinical Trials:Currently Recruiting for 1 Trial
Accepting New Patients
Offers Telehealth
Advanced in Tardive Dyskinesia
Banner Health
Banner Sun Health Research Institute
10515 West Santa Fe Drive, 
Sun City, AZ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

In my spare time... I enjoy hiking, swimming, and playing fetch with my Sheltie dog.

Dr. Shprecher is rated as an Advanced provider by MediFind in the treatment of Tardive Dyskinesia. His top areas of expertise are Movement Disorders, Parkinson's Disease, Lewy Body Dementia (LBD), and Progressive Supranuclear Palsy.

His clinical research consists of co-authoring 61 peer reviewed articles and participating in 8 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Tardive Dyskinesia.

Graduate Institution
Lake Erie College Of Osteopathic Medicine, 2003
Residency
University of Utah Medical Center, Neurology, 2007
Specialties
Neurology
Licenses
Medicine in UT
Medicine in AZ
Board Certifications
American Board Of Psychiatry & Neurology
Fellowships
University of Rochester Medical Center, Movement Disorders, 2009
Hospital Affiliations
Banner Boswell Medical Center
Languages Spoken
English
Spanish
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
CareFirst
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Devoted Health
  • MEDICARE MAPD
  • OTHER MEDICARE
Health Care Services Corporation
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • OTHER COMMERCIAL
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
  • PPO
Health Net

Accepted plan types not found. Please verify directly with the provider.

Highmark
  • EPO
  • HMO
  • PPO
Humana
  • HMO
  • INDEMNITY
  • POS
  • PPO
Managed Medicaid
  • OTHER MANAGED MEDICAID
Medicare
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE PART D
MercyCare
  • EPO
  • HMO
Oscar
  • EPO
  • HMO
  • PPO
PacificSource
  • PPO
SCAN Health Plan
  • INSURANCE PLAN
  • MEDICARE MAPD
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
VibrantRx
  • MEDICARE PDP
  • OTHER MEDICARE
Walgreens
  • MEDICARE DISCOUNT CARD
  • MEDICARE PDP
  • OTHER MEDICARE
Wellcare
  • EPO
  • HMO
  • INSURANCE PLAN
  • MANAGED MEDICAID PLAN
  • MEDICARE MAPD
  • MEDICARE PDP
  • MEDICARE SNP
  • MEDICARE-MEDICAID PLAN
  • OTHER MEDICARE
  • OTHER MEDICARE PART D
View 15 Less Insurance Carriers -

Locations

Banner Sun Health Research Institute
10515 West Santa Fe Drive, Sun City, AZ 85351
Sunday:Closed
Monday:8:00 AM - 5:30 PM
Tuesday:8:00 AM - 5:30 PM
Wednesday:8:00 AM - 5:30 PM
Thursday:8:00 AM - 5:30 PM
Friday:8:00 AM - 5:30 PM
Saturday:Closed
Call: 623-832-6530

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

8 Clinical Trials

Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Enroll -HD: A Prospective Registry Study in a Global Huntington's Disease Cohort
Enrollment Status: Recruiting
Publish Date: February 28, 2024
A Randomized, Double-blind, Placebo-controlled, Phase 2, 6-month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
A Randomized, Double-blind, Placebo-controlled, Phase 2, 6-month Study to Evaluate the Safety, Tolerability and Exploratory Efficacy of CT1812 in Subjects With Mild to Moderate Dementia With Lewy Bodies
Enrollment Status: Completed
Publish Date: June 15, 2025
Intervention Type: Drug
Study Drug: CT1812
Study Phase: Phase 2
North American Prodromal Synucleinopathy Consortium
North American Prodromal Synucleinopathy Consortium
Enrollment Status: Enrolling_by_invitation
Publish Date: November 06, 2024
A Multicenter, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects with Early, Untreated Parkinson Disease
A Multicenter, Prospective, Longitudinal, Digital Assessment Study of Disease Progression in Subjects with Early, Untreated Parkinson Disease
Enrollment Status: Completed
Publish Date: October 08, 2024
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
A Multicenter, Randomized, Double-Blind, Placebo-Controlled, Multiple Dose Study to Evaluate Safety, Tolerability and Efficacy of Orally Administered ENT-01 for the Treatment of Parkinson's Disease-Related Constipation (KARMET)
Enrollment Status: Completed
Publish Date: February 20, 2024
Intervention Type: Drug
Study Drug: ENT-01
Study Phase: Phase 2
The Parkinson's Progression Markers Initiative (PPMI)
The Parkinson's Progression Markers Initiative (PPMI)
Enrollment Status: Completed
Publish Date: November 14, 2023
Intervention Type: Drug
Study Drug: DaTscan
Study Phase: Phase 2
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, With an Active-Treatment Dose-Blinded Period, to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects With Parkinson's Disease
A Multicenter, Randomized, Double-Blind, Placebo-Controlled Study, With an Active-Treatment Dose-Blinded Period, to Evaluate the Efficacy, Safety, Pharmacokinetics, and Pharmacodynamics of BIIB054 in Subjects With Parkinson's Disease
Enrollment Status: Terminated
Publish Date: February 28, 2022
Intervention Type: Drug
Study Drug: BIIB054
Study Phase: Phase 2
Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
Effect of LY3154207 on Cognition in Mild-to-Moderate Dementia Due to Lewy Body Dementia (LBD) Associated With Idiopathic Parkinson's Disease (PD) or Dementia With Lewy Bodies (DLB)
Enrollment Status: Completed
Publish Date: July 23, 2021
Intervention Type: Drug
Study Phase: Phase 2
View 7 Less Clinical Trials

61 Total Publications

A Family With X-Linked Charcot-Marie-Tooth Disease Type 1: A Case for Reclassifying a Variant of Uncertain Significance in GJB1and Review of the Literature.
A Family With X-Linked Charcot-Marie-Tooth Disease Type 1: A Case for Reclassifying a Variant of Uncertain Significance in GJB1and Review of the Literature.
Journal: Journal of clinical neuromuscular disease
Published: September 03, 2025
View All 61 Publications
Similar Doctors
Advanced in Tardive Dyskinesia
Dr. Nicki Niemann
Neurology
Advanced in Tardive Dyskinesia
Dr. Nicki Niemann
Neurology

Sjhmc Physician Services

500 W Thomas Rd, 680 Dhmg St Joseph's Pelvi, 
Phoenix, AZ 
 (14.5 miles away)
602-406-6017
Languages Spoken:
English, Danish
See accepted insurances
Accepting New Patients
Offers Telehealth

Nicki Niemann is a Neurologist in Phoenix, Arizona. Dr. Niemann is rated as a Distinguished provider by MediFind in the treatment of Tardive Dyskinesia. His top areas of expertise are Movement Disorders, Parkinson's Disease, Huntington Disease, Tardive Dyskinesia, and Deep Brain Stimulation. Dr. Niemann is currently accepting new patients.

Advanced in Tardive Dyskinesia
Dr. Daniel J. Savitt
Neurology
Advanced in Tardive Dyskinesia
Dr. Daniel J. Savitt
Neurology

Honorhealth Ambulatory

5090 N 40th St, Suite 250a, 
Phoenix, AZ 
 (17.8 miles away)
602-258-3354
Languages Spoken:
English, Spanish
See accepted insurances
Accepting New Patients
Offers Telehealth

Daniel Savitt is a Neurologist in Phoenix, Arizona. Dr. Savitt is rated as an Advanced provider by MediFind in the treatment of Tardive Dyskinesia. His top areas of expertise are Essential Tremor, Movement Disorders, Parkinson's Disease, and Drug Induced Dyskinesia. Dr. Savitt is currently accepting new patients.

Advanced in Tardive Dyskinesia
Dr. Rebecca L. Jones
Neurology
Advanced in Tardive Dyskinesia
Dr. Rebecca L. Jones
Neurology

Center For Neurology And Spine PC

4400 N 32nd St, Suite 150, 
Phoenix, AZ 
 (17.2 miles away)
602-482-2116
Languages Spoken:
English
See accepted insurances
Accepting New Patients
Offers Telehealth

Rebecca Jones is a Neurologist in Phoenix, Arizona. Dr. Jones is rated as an Advanced provider by MediFind in the treatment of Tardive Dyskinesia. Her top areas of expertise are Memory Loss, Tension Headache, Migraine, Neuralgia, and Vitrectomy. Dr. Jones is currently accepting new patients.

VIEW MORE TARDIVE DYSKINESIA DOCTORS

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Shprecher's expertise for a condition
ConditionClose
  • Elite
  • Movement Disorders
    Dr. Shprecher is
    Elite
    . Learn about Movement Disorders.
    See more Movement Disorders experts
  • Parkinson's Disease
    Dr. Shprecher is
    Elite
    . Learn about Parkinson's Disease.
    See more Parkinson's Disease experts
  • Distinguished
  • Lewy Body Dementia (LBD)
    Dr. Shprecher is
    Distinguished
    . Learn about Lewy Body Dementia (LBD).
    See more Lewy Body Dementia (LBD) experts
  • Progressive Supranuclear Palsy
    Dr. Shprecher is
    Distinguished
    . Learn about Progressive Supranuclear Palsy.
    See more Progressive Supranuclear Palsy experts
  • Advanced
  • Chorea
    Dr. Shprecher is
    Advanced
    . Learn about Chorea.
    See more Chorea experts
  • Drug Induced Dyskinesia
    Dr. Shprecher is
    Advanced
    . Learn about Drug Induced Dyskinesia.
    See more Drug Induced Dyskinesia experts
  • Essential Tremor
    Dr. Shprecher is
    Advanced
    . Learn about Essential Tremor.
    See more Essential Tremor experts
  • Muscle Spasms
    Dr. Shprecher is
    Advanced
    . Learn about Muscle Spasms.
    See more Muscle Spasms experts
  • Tardive Dyskinesia
    Dr. Shprecher is
    Advanced
    . Learn about Tardive Dyskinesia.
    See more Tardive Dyskinesia experts
  • Tourette Syndrome
    Dr. Shprecher is
    Advanced
    . Learn about Tourette Syndrome.
    See more Tourette Syndrome experts
  • Experienced
  • Anosmia
    Dr. Shprecher is
    Experienced
    . Learn about Anosmia.
    See more Anosmia experts
  • Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency
    Dr. Shprecher is
    Experienced
    . Learn about Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency.
    See more Aromatic L-Amino Acid Decarboxylase (AADC) Deficiency experts
  • Benign Essential Blepharospasm
    Dr. Shprecher is
    Experienced
    . Learn about Benign Essential Blepharospasm.
    See more Benign Essential Blepharospasm experts
  • CACH Syndrome
    Dr. Shprecher is
    Experienced
    . Learn about CACH Syndrome.
    See more CACH Syndrome experts
  • Corticobasal Degeneration
    Dr. Shprecher is
    Experienced
    . Learn about Corticobasal Degeneration.
    See more Corticobasal Degeneration experts
  • Dopa-Responsive Dystonia
    Dr. Shprecher is
    Experienced
    . Learn about Dopa-Responsive Dystonia.
    See more Dopa-Responsive Dystonia experts
View All 19 Experienced Conditions
Want to save this doctor for later?
Sign Up
Is this your doctor?
Find A Second Opinion
Not sure about your diagnosis?
Check Your Symptoms
 
 
 
 
Learn about our expert tiers
Learn More
Are you the provider on this profile?
Claim Profile
For Patients
  • Our Story
  • How MediFind Works
  • Conditions A-Z
  • Doctor Directory
  • Symptoms Directory
  • Procedures Directory
  • Treatment Directory
  • Drug Directory
  • Infusion Center Finder
  • FAQ
  • Contact Us
For Providers and Practices
  • Claim Your Profile
  • Newsroom
Business Solutions
  • Provider
  • Network Solutions
Additional Resources
  • Consumer Health Data Privacy Policy
  • Privacy Policy
  • Terms of Use
  • Advertising Policy
  • Content Policy
Subscribe to our newsletter

Sign up to stay informed about MediFind and get wellness sent your way.

Close

    By subscribing, I agree to MediFind's Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.

    Bullet PinMediFind
    Follow us on
    This information is not intended as a substitute for informed medical advice. You should work with a licensed professional to diagnose and treat health conditions. We let the data speak for itself, MediFind does not endorse any healthcare providers.
    © 2026 All Rights Reserved

    Request an Appointment

    If you are experiencing a medical emergency, call 9-1-1.

    MediFind will contact the provider for your appointment request. You’ll receive status updates by email. Your provider or MediFind will reach out to you directly by phone or email to schedule your appointment or request additional information.

    Patient Details

    This information is for the patient who will be seen at the appointment.

      Close

      Returning patient? Use your address on file with the provider.

      Insurance Details

      Please provide information of the primary insurance holder as the practice may require this information to schedule.

      Insurance Provider *
      Insurance ProviderClose

      Appointments Details

      Let’s get more information about your appointment.

              0 / 1000
              0 / 1000
              By pressing the Submit button you are agreeing to MediFind’s Terms of Use, Privacy Policy and Consumer Health Data Privacy Policy, as applicable.